2 results
Approved WMOCompleted
To improve symptomatology in severe chronic failure patients.
Approved WMOWill not start
In a small pilot study to investigate possible occurence of blood chemistry deviations and / or a tamponade after the application of ACF-Matrix haemostat in the (L)IMA bed.